ClinicalTrials.gg
RecruitingNCT06255132Updated Feb 13, 2024

Automated Pupillometry in Patients Underwent Cardiac Surgery to Predict Postoperative Delirium

An interventional study of Automated pupillometer NPi-200 in Postoperative Delirium, sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-13.

Sponsored by Azienda Ospedaliera Universitaria Integrata Verona · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Registered 7 months after the study started (first participant enrolled Mar 2023, registered Oct 2023).
  • Started Mar 2023; still recruiting 3 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Emergence Delirium with a site in Italy — 5 open to participants now, 5 under way, none of them phase 3. Emergence Delirium · Italy.

Started
2023
with 1 other
No phase
5 of 13
3 open now
Registered
11th of 13
by date
Lead sponsor
1 of 13
Azienda Ospedaliera Universitaria Integrata Verona

Among the 13 studies in Emergence Delirium with a site in Italy, this one is one of 2 that started in 2023, is one of 5 with no phase, and was the 11th registered.

Emergence Delirium

753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.

Browse Emergence Delirium studies →

Open to participants now

5 of the 13 studies in Emergence Delirium with a site in Italy are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Emergence Delirium with a site in Italy, or all of them as a file.
02

Study summary

The rate of postoperative delirium in patients who underwent cardiac surgery is very high. Different predictors and/or scores were studied for the prediction of Post Operative Delirium (POD)after heart surgery, but none of them was validated. The investigators aim to explore the role of pupillary alterations during anesthesia in open-heart surgery.

The goal of this prospective study is to evaluate if pupil alterations during cardiac surgery, evaluated by an automated pupillometer (NPi-200) ( AP), could predict postoperative delirium.

Read the detailed description

Consent was obtained during the hospitalization before the planned surgery.

On the day of surgery, before general anesthesia is started, Near-infrared spectroscopy (NIRS) sensors are applied to the patient's forehead bilaterally and the baseline value is recorded. Pupils' variables (i.e., diameter, % constriction, constriction velocity, dilation velocity, latency, NPi) are also recorded from both the right and left eye with AP (NPi-200).

From the induction of anesthesia, pupillary variables in both eyes are recorded and measured every 30' such as the concomitant NIRS values (at least one measurement per eye per operative phase). Moreover, hemodynamic and respiratory parameters concomitant with the pupillary measurements are measured.

Following surgery, the patient is transferred to the Cardiac Intensive Care Unit. There, NIRS monitoring as as well as automated pupillometry measurements will be maintained until the patient regains consciousness (defined as RASS sedation scale >-3).

Once the patient has regained consciousness (RASS>-3), is assessed twice a day (morning and afternoon) with the Confusion assessment method-intensive care unit (CAM-ICU) score by the nursing staff and/or medical staff. The presence or absence of POD will then be reported as well as any pharmacological and non-pharmacological treatments.

Any neurological complications and diagnostic investigations arising in the post-operative period will also be noted.

03

Conditions studied

  • Postoperative Delirium

Browse trials for

Keywords

  • automated pupillometry
  • cardiac surgical procedures
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients undergoing elective open cardiac surgery (>18 yr)
  • Elective open cardiac surgery and cardiopulmonary bypass

Exclusion criteria

Exclusion Criteria:

  • Patients \<18 years of age
  • Emergency surgeries
  • Heart operations, not including extracorporeal circulation
  • Surgery for aortic arch dissection with hypothermia and/or circulatory arrest
  • Patients affected by psychiatric disorders undergoing with or without neuroleptic therapy
  • Patients who have the refused consent
  • Patients with ocular problems (acute or previous trauma to one or both eyes, blindness, ocular prosthesis)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Patients undergoing open heart surgery

    Device: Automated pupillometer NPi-200

Interventions

  • DeviceAutomated pupillometer NPi-200

    Pupillary variables in both eyes are recorded and measured with NPi-200 every 30 minutes from the induction of anesthesia. At the end of the surgery, the patient is transferred to the intensive care unit (ICU), and the pupillary variables are recorded until the patient regains consciousness (Richmond agitation sedation scale, RASS\>-3). Specific hemodynamic, respiratory, surgical, and EBP data are also recorded as well as NIRS variables. As soon as the patient had regained consciousness (RASS \> 3), they were assessed for delirium for a total period of five days. Nursing and/or medical staff administered the CAM-ICU score to patients twice a day (morning and afternoon).

06

What researchers measure

Primary outcomes

  1. Correlation between neurological pupil index (NPi) and Post-operative delirium

    We want to relate pupillary reactivity, assessed with automated pupillometry such as the Neurological pupil index (numerical value:0-5) during surgery, with Postoperative delirium (assessed with CAM-ICU score during the first 5 postoperative days).

    Time frame: Intraoperative (day 0)

Secondary outcomes

  1. Correlation between early prediction model for delirium (E-PRE-DELIRIC) and POD

    E-PREDELIRIC is a standard prediction model for ICU delirium (%) and is calculated at ICU admission. We aim to evaluate the correlation between the model and Postoperative delirium in cardiovascular patients

    Time frame: E-PREDELIRIC is calculated at ICU admission ( day 0)

  2. Correlation between regional cerebral saturation (rSO2) and POD occurrence

    Regional cerebral saturation (rSO2) ranges between 0 and 100% and is a standard of care during open heart surgery. We want to evaluate the correlation between intraoperative cerebral saturation during surgery and POD.

    Time frame: rSO2 is monitored during surgery (Day 0)

  3. Correlation between Cardiopulmonary bypass duration and POD.

    Cardiopulmonary bypass duration within heart surgery is variable (min), depending on different surgical factors. We aim to evaluate if the duration of CPB could be related to POD occurrence

    Time frame: Intraoperative

  4. Multivariate model for POD prediction.

    a multivariate analysis will be performed to build a prediction model for postoperative delirium in the specific population of cardiovascular patients who underwent open heart surgery.

    Time frame: Day 0

07

Study locations

1 of 1 sites recruiting
  • Unit of Cardiothoracic Anesthesia and Intensive Care, University hospital of Verona
    Verona, Vr 37126, Italy
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Sep 2024, 18 months after the start.

Of 186 non-industry interventional studies with no phase under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 18 months is close to that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2023
First posted
Feb 13, 2024
StartActual
Mar 9, 2023
Primary completionEst.
Sep 2024
CompletionEst.
Mar 2025
Last update
Feb 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06255132
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Responsible party
Sponsor
First posted
Feb 13, 2024
Start date
Mar 9, 2023
Primary completion
Sep 2024 (estimated)
Completion
Mar 2025 (estimated)
Last update
Feb 13, 2024

Study contacts

Federico Romagnosi, MD
Contact
federico.romagnosi@aovr.veneto.it
0458122621
Leonardo Gottin, Prof.
study director · Universita di Verona
Federico Romagnosi, MD
principal investigator · Universita di Verona

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion